';
Maternal Mental Health and Substance Use Disorder Discussion
Friday, February 19, 2021 from 11:00 am – 1:00 pm
The Pennsylvania Commission for Women is hosting this event to bring awareness to maternal mental health and the stigma associated with substance use disorders. The panelists will discuss Opioid Use Disorder, Fetal Alcohol Spectrum Disorders (FASDs), and the Healthy Families America Safe Start program. There will also be a brief question and answers (Q&A) session at the end of the presentation. This event will be recorded and made available on the commission website.
Panelists:
For more information on this event, see this flyer.
The Office of Mental Health and Substance Abuse Services (OMHSAS) has released guidance information confirming that OMHSAS programs are indeed in Phase 1A of Pennsylvania’s Interim Vaccination Plan for providers who are seeking to obtain vaccinations for their programs. While this particular response focuses on the Federal Pharmacy Partnership Program as a pathway to vaccinations, we are recommending that providers seek all available options that include federally-qualified health centers (FQHC’s), hospital and regional health systems, and county boards of health.
The Pennsylvania Department of Health (DOH) has made available a map of vaccine providers to assist your efforts. Please contact your RCPA policy director for any assistance you may need in your efforts. RCPA will continue to update its members on any changes in the plan.
OMHSAS Guidance
In order to facilitate vaccine distribution across Pennsylvania, Secretary of Health Dr. Rachel Levine signed an order on December 30, 2020 directing that at least ten percent of each vaccine shipment to hospitals, health systems, federally-qualified health centers, and pharmacies (collectively called “vaccine providers”) be designated for non-hospital affiliated health-care personnel who would otherwise be included in Phase 1A of Pennsylvania’s Interim Vaccination Plan, which was updated on Friday, January 8, 2021.
Health-care personnel as defined in Phase 1A include:
Long-term care facility staff are considered health-care personnel above, and long-term care facility residents are also in Phase 1A. Long-term care facilities as defined in Phase 1A include:
The Department of Health recently released a map of vaccine providers who can administer a COVID-19 vaccine to anyone covered by Phase 1A. Anyone covered under Phase 1A who has not yet received a COVID-19 vaccine can contact any of these providers to check availability and schedule their vaccination, but we encourage providers to contact sites and coordinate for their employees who are eligible. Employees should be prepared to show proof of employment. This map is being updated regularly, so please keep checking for new locations with vaccine supply and available appointments.
Long-term care facility staff and residents may be eligible for the Federal Pharmacy Partnership Program for long-term care facilities. The Federal Pharmacy Partnership Program is currently prioritizing skilled nursing facilities at this time. If your facility is enrolled in the program, CVS and Walgreens may have already reached out to schedule a vaccination date with you. However, if your facility has not already scheduled a vaccination date with CVS or Walgreens, you are encouraged to contact your local vaccine provider. The Department of Human Services (DHS) and Department of Health are also working together on additional solutions to expedite vaccine distribution to DHS-licensed facilities. Please keep track of who in your facility has already received a vaccine.
As vaccine supply is limited, it may take some time to find a vaccination provider and appointment. Thank you for your patience through this process, and most importantly, thank you for being united in our collective fight against COVID-19.
The Pennsylvania Commission on Crime and Delinquency (PCCD) recently put out three funding announcements related to the Substance Abuse Education Demand and Reduction Act. Non-profit organizations are eligible to apply for all three solicitations; however, the Categories Two and Three Funding Announcement is more specific in what type of nonprofit can apply.
Substance Abuse Education and Demand Reduction Category 1 Funds – Adult and Youth Focus
Substance Abuse Education and Demand Reduction Category Two and Three Funds
The Pennsylvania Commission on Crime and Delinquency’s (PCCD) Office of Justice Programs announces the availability of Substance Abuse Education and Demand Reduction (SAEDR) Category Two and Category Three funds to support the implementation of strategies aimed at combating opioid/heroin overdoses in Pennsylvania communities. Under this solicitation, funds are being made available for projects designed to educate the public about the dangers of substance use and/or reduce demand for these substances under the following two categories:
For more information about PCCD grants, please visit the PCCD website. If you are interested in receiving notices when PCCD funding announcements become available, please sign up for notifications here.
Yesterday, the Wolf Administration launched an interactive vaccine provider map. This map shows enrolled vaccine providers and indicates which providers have received vaccines to date. In addition to highlighting the status of vaccines available, this map also includes contact information to connect Phase 1A eligible individuals who are not affiliated with a hospital/health system with vaccines.
The map is also provided on the Department of Health’s (DOH’s) main COVID-19 vaccine page. DOH will continue to update this resource as information becomes available.
The Pennsylvania Department of Health (DOH) is supplying guidance on COVID-19 vaccination for providers. The information in 2021- PAHAN- 545- 01-06- ADV should be used to supplement other relevant guidance documents and guide the implementation of public health expectations for vaccine providers.
Key messages included in the guidance include: